Rituximab Combining Bortezomib Versus Rituximab in Management of ITP

NCT03443570 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Immune Thrombocytopenia
Purpura, Thrombocytopenic, Idiopathic

Interventions

DRUG: Rituximab
DRUG: Bortezomib

Sponsor

Shandong University

Collaborators

[object Object]
[object Object]